Trademarkia Logo

Canada

C$
CLINIPRIME
FORMALIZED

on 4 Aug 2022

Last Applicant/ Owned by

CHARLES RIVER LABORATORIES INC.

251 Ballardvale StreetWilmington, MA 01887

US

Serial Number

2202295 filed on 4th Aug 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

CLINIPRIME

Trademark usage description

biological tissue, namely, bone marrow, cord blood, normal peripheral blood, and mobilized peripheral blood, for use in scientific and medical researc Read More

Classification Information


Class [001]
Biological tissue, namely, bone marrow, cord blood, normal peripheral blood, and mobilized peripheral blood, for use in scientific and medical research; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells for research purposes; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Biological tissue, namely, blood for scientific or medical research use


Classification kind code

11

Class [005]
Cells for medical or clinical use; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes


Classification kind code

11

Class [039]
Distribution services, namely, delivery of human-derived donated blood products and isolated cells to hospitals, academic institutions, biotech and pharma companies, and other related research organizations; Storage of blood; Transport, delivery, packaging, and storage of human-derived biological material


Classification kind code

11

Class [044]
Collection and preservation of human blood


Classification kind code

11

Mark Details


Serial Number

2202295

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 11th Aug 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 4th Aug 2022
Filed
Submitted for opposition 1
on 4th Aug 2022
Created
Submitted for opposition 31
on 4th Aug 2022
Formalized